Stay updated with breaking news from Nasdaq ango. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) has been given a consensus rating of “Hold” by the seven brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has assigned a strong […] ....
Equities analysts forecast that AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) will announce $0.01 earnings per share for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for AngioDynamics’ earnings, with the highest EPS estimate coming in at $0.01 and the lowest estimate coming in at $0.00. The business is scheduled to announce […] ....
AngioDynamics (NASDAQ:ANGO – Get Rating) updated its FY 2022 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $-0.020-$0.020 for the period, compared to the Thomson Reuters consensus estimate of $-0.010. The company issued revenue guidance of $310 million-$315 million, compared to the consensus revenue estimate of $313.65 million. ANGO has […] ....
AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Stock analysts at Oppenheimer lowered their Q4 2022 earnings per share (EPS) estimates for shares of AngioDynamics in a research note issued to investors on Friday, April 8th. Oppenheimer analyst S. Lichtman now expects that the medical instruments supplier will post earnings per share of $0.01 for the […] ....
Equities analysts expect that AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) will post sales of $81.81 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for AngioDynamics’ earnings. The lowest sales estimate is $81.60 million and the highest is $82.00 million. AngioDynamics reported sales of $76.84 million in the same quarter […] ....